Peptide-based immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide-based immunotherapy, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. [Phase 2]